NCORP Tissue Procurement Protocol: An NCI Cancer Moonshot Study
Genetic Analysis of Blood and Tissue Samples From Participants With Advanced Cancer
Sponsor: NIH
Enrolling: Male and Female Patients
IRB Number: AAAS4112
U.S. Govt. ID: NCT03707574
Contact: Research Nurse Navigator: 212-342-5162 /
Additional Study Information: Major advances are being made in the treatment of cancer. One such advance involves the use of targeted treatments designed to work against specific molecular alterations in a given patients tumor. However, in most cases, we are not yet able to predict which patients will benefit from a specific targeted treatment, even if a tumor harbors the alteration that is the target of that treatment. Furthermore, although many patients benefit from targeted treatments for a period of time, the tumor will often become resistant to the treatment and start growing again at some point. The purpose of this study is to understand why certain patients respond to targeted treatments and others do not. The other major purpose of this study is to understand why targeted treatments stop working after initially helping. To do this, the researchers will collect a tumor biopsy before patients started a targeted treatment, and again the treatment initially helps but then stops working. In some cases, patients physicians will be given the results of part of the testing.
This study is closed
Matthew Ingham, MD
Do You Qualify?
Are you 18 years of age or older? Yes No
Do you have an advanced malignancy? Yes No
Are you willing to provide tissue and blood samples for this study? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Research Nurse Navigator